Cara Therapeutics, Inc.

NASDAQ: CARA
$19.15
+$0.17 (+0.9%)
Closing price January 22, 2021
Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic kidney disease.